K B Sadow1, J M Chamberlain. 1. Department of Pediatrics, George Washington University School of Medicine and Health Sciences and Children's Hospital, Washington, DC, USA.
Abstract
OBJECTIVE: To evaluate the yield of blood cultures obtained from immunocompetent children admitted for cellulitis in the post-Haemophilus influenzae type b (Hib) vaccine era and to determine whether these cultures are cost-effective. DESIGN: Retrospective case series. SETTING: Urban pediatric emergency department. Study Population. Patients 2 days to 22 years of age admitted with cellulitis from 1994 through 1995. MEASUREMENTS AND RESULTS: Of 381 patients identified, 266 (70%) had blood cultures and 243 of these children were enrolled. Data recorded include demographics, immunization status, initial clinical appearance, antibiotic pretreatment, preexisting illness, location and precipitating cause of cellulitis, white blood cell count, and band-to-neutrophil ratio (BNR). Blood cultures were categorized as positive, negative, or contaminant. Five cultures (2%) were positive, and 13 (5.4%) were contaminants. The positive blood cultures grew streptococcus and staphylococcus organisms, and none of the children were bacteremic with H influenzae. All patients with group A beta-hemolytic streptococcus had active varicella. The mean age was lower (26 vs 75 months) in those with a positive blood culture, and mean BNR was higher (0.32 vs 0.07). Patient management did not change for bacteremic patients with uncomplicated cellulitis. All repeat cultures were negative. The cumulative charge for all blood cultures was $50 986. CONCLUSIONS: Blood cultures are not cost-effective and are more frequently contaminated than positive in the evaluation of a patient with uncomplicated cellulitis. Since introduction of the H influenzae type b vaccine, the most common organisms are streptococci. Using a BNR = 0.20 as a threshold for sending blood cultures, we would have missed one positive culture, but would have avoided blood cultures in 213 patients (88%) with an estimated savings of $42 850.
OBJECTIVE: To evaluate the yield of blood cultures obtained from immunocompetent children admitted for cellulitis in the post-Haemophilus influenzae type b (Hib) vaccine era and to determine whether these cultures are cost-effective. DESIGN: Retrospective case series. SETTING: Urban pediatric emergency department. Study Population. Patients 2 days to 22 years of age admitted with cellulitis from 1994 through 1995. MEASUREMENTS AND RESULTS: Of 381 patients identified, 266 (70%) had blood cultures and 243 of these children were enrolled. Data recorded include demographics, immunization status, initial clinical appearance, antibiotic pretreatment, preexisting illness, location and precipitating cause of cellulitis, white blood cell count, and band-to-neutrophil ratio (BNR). Blood cultures were categorized as positive, negative, or contaminant. Five cultures (2%) were positive, and 13 (5.4%) were contaminants. The positive blood cultures grew streptococcus and staphylococcus organisms, and none of the children were bacteremic with H influenzae. All patients with group A beta-hemolytic streptococcus had active varicella. The mean age was lower (26 vs 75 months) in those with a positive blood culture, and mean BNR was higher (0.32 vs 0.07). Patient management did not change for bacteremic patients with uncomplicated cellulitis. All repeat cultures were negative. The cumulative charge for all blood cultures was $50 986. CONCLUSIONS: Blood cultures are not cost-effective and are more frequently contaminated than positive in the evaluation of a patient with uncomplicated cellulitis. Since introduction of the H influenzae type b vaccine, the most common organisms are streptococci. Using a BNR = 0.20 as a threshold for sending blood cultures, we would have missed one positive culture, but would have avoided blood cultures in 213 patients (88%) with an estimated savings of $42 850.
Authors: R Marom; W Sakran; J Antonelli; Y Horovitz; Y Zarfin; A Koren; D Miron Journal: Arch Dis Child Fetal Neonatal Ed Date: 2007-01 Impact factor: 5.747
Authors: Samir S Shah; Maria H Dugan; Louis M Bell; Robert W Grundmeier; Todd A Florin; Elizabeth M Hines; Joshua P Metlay Journal: Pediatr Infect Dis J Date: 2011-06 Impact factor: 2.129
Authors: G Peralta; E Padrón; M P Roiz; I De Benito; J C Garrido; F Talledo; M J Rodríguez-Lera; L Ansorena; M B Sánchez Journal: Eur J Clin Microbiol Infect Dis Date: 2006-10 Impact factor: 5.103